Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Patients with castration-resistant prostate cancer (CRPC) receive second-generation androgen-deprivation therapy, but frequently experience relapse or do not respond. Understanding the genetic mechanisms of resistance will help to identify strategies and biomarkers that are essential for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, G. Celine, Hwang, Justin, Wankowicz, Stephanie A.M., Zhang, Zhenwei, Liu, David, Cibulskis, Carrie, Gaviola, Glenn C., Ghazikhanian, Varand, McKay, Rana R., Bubley, Glenn J., Carter, Scott L., Balk, Steven P., Hahn, William C., Taplin, Mary-Ellen, Van Allen, Eliezer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446377/
https://www.ncbi.nlm.nih.gov/pubmed/32913968
http://dx.doi.org/10.1200/PO.17.00140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446377/
https://www.ncbi.nlm.nih.gov/pubmed/32913968
http://dx.doi.org/10.1200/PO.17.00140

Ejemplares similares